Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 302

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 302
---
                                                                                                                 
 to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written 
 consent or electronic transmission;                                                                                                     |

| ● | provide that our stockholders                                                                                                     
 seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of 
 stockholders must provide advance notice in writing, and also specify requirements as to the form and content of a stockholder’s  
 notice;                                                                                                                           |

| ● | provide that special meetings                                                                                                           
 of our stockholders may be called only by the chairperson of the Board, our chief executive officer or by the Board pursuant to a       
 resolution adopted by a majority of the total number of authorized directors; and                                                       |
| ● | not provide for cumulative                                                                                                              
 voting rights, therefore allowing the holders of a majority of the shares of Common Stock entitled to vote in any election of directors 
 to elect all of the directors standing for election if they should so choose.                                                           |

The amendment of a number
of these provisions would require approval by the holders of at least 66 2/3% of the voting power of all of our then-outstanding capital
stock entitled to vote generally in the election of directors, voting together as a single class.

<div align='center'>176</div>

The combination of these
provisions will make it more difficult for our existing stockholders to replace the Board, as well as for another party to obtain control
of us by replacing the Board. Since the Board has the power to retain and discharge our officers, these provisions could also make it
more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization of undesignated
preferred stock makes it possible for the Board to issue preferred stock with voting or other rights or preferences that could impede
the success of any attempt to change our control.

These provisions are intended
to enhance the likelihood of continued stability in the composition of our Board and our policies and to discourage coercive takeover
practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and to discourage
certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender
offers for our shares and may have the effect of delaying changes in our control or management. As a consequence, these provisions may
also inhibit fluctuations in the market price of our stock.

Choice of Forum